APELLIS PHARMACEUTICALS INC

CUSIP: 03753UAB2 Class: NOTE 3.500% 9/1

WELLINGTON MANAGEMENT GROUP LLP's Holding History (CIK: 0000902219)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,130,000 Value ($000) $1,180 Avg Close — Range —
Q3 2025
Shares 1,130,000 Value ($000) $1,153 Avg Close — Range —
Q2 2025
Shares 1,285,000 Value ($000) $1,286 Avg Close — Range —
Q1 2025
Shares 1,285,000 Value ($000) $1,342 Avg Close — Range —
Q4 2024
Shares 1,285,000 Value ($000) $1,499 Avg Close — Range —
Q3 2024
Shares 1,285,000 Value ($000) $1,420 Avg Close — Range —
Q2 2024
Shares 1,285,000 Value ($000) $1,658 Avg Close — Range —
Q1 2024
Shares 1,285,000 Value ($000) $2,086 Avg Close — Range —
Q4 2023
Shares 1,285,000 Value ($000) $2,106 Avg Close — Range —
Q3 2023
Shares 1,285,000 Value ($000) $1,591 Avg Close — Range —
Q2 2023
Shares 1,285,000 Value ($000) $3,085 Avg Close — Range —
Q1 2023
Shares 1,285,000 Value ($000) $2,390 Avg Close — Range —
Q4 2022
Shares 2,476,000 Value ($000) $3,825 Avg Close — Range —
Q3 2022
Shares 3,853,000 Value ($000) $7,491 Avg Close — Range —
Q2 2022
Shares 5,788,000 Value ($000) $8,639 Avg Close — Range —
Q1 2022
Shares 6,025,000 Value ($000) $9,544 Avg Close — Range —
Q4 2021
Shares 5,825,000 Value ($000) $8,807 Avg Close — Range —
Q3 2021
Shares 5,015,000 Value ($000) $6,151 Avg Close — Range —
Q2 2021
Shares 4,490,000 Value ($000) $8,279 Avg Close — Range —
Q1 2021
Shares 1,590,000 Value ($000) $2,232 Avg Close — Range —
Q4 2020
Shares 1,650,000 Value ($000) $2,769 Avg Close — Range —
Q3 2020
Shares 1,650,000 Value ($000) $1,764 Avg Close — Range —